Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...
Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...
The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...
Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...
Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...
Continuous chromatography is poised to become an increasingly important part of monoclonal antibody manufacturing strategies.
From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...
Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...
Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...
Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...
The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.
HPLC continues to meet such demands through advances in column chemistry, instrument performance, and software, allowing laboratories to characterize increasingly complex molecules with greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results